Zoekresultaten - Brian L. Wiens

  • Toon 1 - 9 resultaten van 9
Verfijn jouw resultaten
  1. 1
    First and Subsequent Cycle Use of Pegfilgrastim Prevents Febrile Neutropenia in Patients With Breast Cancer: A Multicenter, Double-Blind, Placebo-Controlled Phase III Study

    First and Subsequent Cycle Use of Pegfilgrastim Prevents Febrile Neutropenia in Patients With Breast Cancer: A Multicenter, Double-Blind, Placebo-Controlled Phase III Study door Charles L. Vogel, Marek Z. Wojtukiewicz, Robert R. Carroll, Sergei Tjulandin, Luis Javier Barajas-Figueroa, Brian L. Wiens, Theresa Neumann, Lee S. Schwartzberg

    Gepubliceerd in 2005
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  2. 2
    Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients

    Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients door Alexander Cohen, Robert A. Harrington, Samuel Z. Goldhaber, Russell D. Hull, Brian L. Wiens, Alex Gold, Adrian F. Hernandez, C. Michael Gibson

    Gepubliceerd in 2016
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  3. 3
    Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity

    Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity door Deborah Siegal, John T. Curnutte, Stuart J. Connolly, Genmin Lu, Pamela B. Conley, Brian L. Wiens, Vandana Mathur, Janice Castillo, Michele Bronson, Janet M. Leeds, F. Mar, Alex Gold, Mark Crowther

    Gepubliceerd in 2015
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  4. 4
    Efficacy and Safety of Darusentan in Patients With Resistant Hypertension: Results From a Randomized, Double‐Blind, Placebo‐Controlled Dose‐Ranging Study

    Efficacy and Safety of Darusentan in Patients With Resistant Hypertension: Results From a Randomized, Double‐Blind, Placebo‐Controlled Dose‐Ranging Study door Henry R. Black, George L. Bakris, Michael A. Weber, Robert Weiss, Mahfouz El Shahawy, Richard N Marple, Georges Tannoury, Stuart L. Linas, Brian L. Wiens, Jennifer V. Linseman, Robert L. Roden, Michael J. Gerber

    Gepubliceerd in 2007
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  5. 5
    A Controlled Trial of a Formalin-Inactivated Hepatitis A Vaccine in Healthy Children

    A Controlled Trial of a Formalin-Inactivated Hepatitis A Vaccine in Healthy Children door Alan Werzberger, Barbara Mensch, Barbara J. Kuter, Leora Brown, John A. Lewis, Robert D. Sitrin, William J. Miller, Daniel Shouval, Brian L. Wiens, Gary Calandra, John L. Ryan, P. J. Provost, David R. Nalin

    Gepubliceerd in 1992
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  6. 6
    Ambrisentan for the Treatment of Pulmonary Arterial Hypertension

    Ambrisentan for the Treatment of Pulmonary Arterial Hypertension door Nazzareno Galiè, Horst Olschewski, Ronald J. Oudiz, Ferrán Torres, Adaani Frost, Hossein Ardeschir Ghofrani, David B. Badesch, Michael D. McGoon, Vallerie V. McLaughlin, Ellen B. Roecker, Michael J. Gerber, Christopher Dufton, Brian L. Wiens, Lewis J. Rubin

    Gepubliceerd in 2008
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  7. 7
    Efficacy and safety of izokibep in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study

    Efficacy and safety of izokibep in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study door Peter C. Taylor, Philip J. Mease, Kurt de Vlam, Shephard Mpofu, Dieter Wetzel, Anne M. Stevens, Brian L. Wiens, Lisa Osterling Koskinen, S. Ohlman, Joachim Feldwisch, Fredrik Y. Frejd, Nikolai C. Brun, Jan Brandt-Juergens, Edit Drescher, Eva Dokoupilová, Anna Rowińska-Osuch, Nadia Abdel-Kader Martin, Frank Behrens

    Gepubliceerd in 2025
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  8. 8
    A randomized, placebo‐controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis

    A randomized, placebo‐controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis door Scott L. Friedman, Vlad Ratziu, Stephen A. Harrison, Manal F. Abdelmalek, Guruprasad P. Aithal, Juan Caballería, Sven Francque, Geoffrey C. Farrell, Kris V. Kowdley, Antonio Craxı̀, Krzysztof Simon, Laurent Fischer, Liza Melchor‐Khan, Jeffrey Vest, Brian L. Wiens, Pamela Vig, Star Seyedkazemi, Zachary Goodman, Vincent Wai‐Sun Wong, Rohit Loomba, Frank Tacke, Arun J. Sanyal, Éric Lefebvre

    Gepubliceerd in 2017
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  9. 9
    Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors

    Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors door Stuart J. Connolly, Truman J. Milling, John W. Eikelboom, C. Michael Gibson, John T. Curnutte, Alex Gold, Michele Bronson, Genmin Lu, Pamela B. Conley, Peter Verhamme, Jeannot Schmidt, Saskia Middeldorp, Alexander T. Cohen, Jan Beyer‐Westendorf, Pierre Albaladejo, José López‐Sendón, Shelly Goodman, Janet M. Leeds, Brian L. Wiens, Deborah Siegal, Elena Zotova, Brandi Meeks, Juliet Nakamya, W. Ting Lim, Mark Crowther

    Gepubliceerd in 2016
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:

Zoekinstrumenten: